Hughes & Associates

By Jay Chapman - Building Careers. Building Teams. Advancing Science - Exec & Tech Search Experts for Pharma and Biotech

[Hughes & Associates @haallcofficial]

Before approving a 2027 role, ask:

What milestone will it protect?
What decision will this hire improve?
When is the capability needed?
Must it be a permanent role?
Which skills are truly essential?

Start with the work. Then define the hire.

https://t.co/lkaUrtWfut

[Hughes & Associates @haallcofficial]

Scientific leadership can begin before a new title arrives. 🔬

Our latest blog explores how mentoring, sharing knowledge, and everyday contributions can shape that growth.

Read “Growing Into Scientific Leadership”: https://t.co/2oZ1SWIVQG

[Hughes & Associates @haallcofficial]

Behind every breakthrough, there's probably a very good cup of coffee. 🍵

Because great science takes curiosity, collaboration, and sometimes... one more cup before the next big idea.

Here's to the people turning complex questions into meaningful discoveries!

[Hughes & Associates @haallcofficial]

If your scientific team had a group chat name, what would it be?

“One More Question…”
“Connecting the Dots”
“What Does the Data Say?”

Behind great science are people who ask, rethink, and help each other move forward.

What do you appreciate most about the people on your team?

[Hughes & Associates @haallcofficial]

Looking forward to the conversations ahead at ACoP 2026.

Jay Chapman will be attending on our behalf, reconnecting with colleagues and exchanging ideas on scientific progress and teams’ next steps.

Attending? We’d be happy to connect.

[Hughes & Associates @haallcofficial]

What do biopharma layoffs mean for scientific teams?

Our latest podcast explores how restructuring reshapes scientific work and why headcount alone doesn’t reveal which capabilities are affected.

▶️ Full episode: https://t.co/YE3k5mIcFh

#Biopharma #LifeSciences

[Hughes & Associates @haallcofficial]

What is the Pharmacometrics hiring market telling us in 2026? 📊

We looked at where demand is emerging, the capabilities appearing most often, and how hiring expectations are evolving.

Read the full report on our website.

[Hughes & Associates @haallcofficial]

Onsite, hybrid, or remote?

Across the #ClinicalPharmacology jobs we tracked in 2026, structured hybrid work is becoming increasingly visible, while fully remote opportunities remain more selective.

Swipe through for the key trends we’re seeing.

[Hughes & Associates @haallcofficial]

Our Q2 2026 Biopharma Market Update is now live.

We look at renewed venture investment, M&A activity, easing layoffs, and what these shifts may mean for specialized scientific talent.

Read the full update: https://t.co/dqd9P29mkZ

[Hughes & Associates @haallcofficial]

How is the #DMPK talent market evolving?

Our latest podcast explores where hiring demand is strongest, why scientific leaders are commanding premium compensation, and what these trends mean for biotech and pharma organizations.

🎧 Watch the clip.

[Hughes & Associates @haallcofficial]

The role of #DMPK continues to evolve beyond traditional ADME and PK responsibilities.

Our DMPK Talent Market Report 2026 explores hiring trends, compensation, work models, and the scientific and leadership capabilities shaping the market.

https://t.co/ijGQAzY9nX

[Hughes & Associates @haallcofficial]

Our latest Q2 Clinical Pharmacology Market Report examines where demand is strongest, how organizations are structuring their teams, and what's shaping hiring decisions across biotech and pharma.

Catch full conversation on our website: https://t.co/YE3k5mIcFh

[Hughes & Associates @haallcofficial]

Today we recognize the enduring values of freedom, opportunity, and innovation that continue to inspire progress across the United States.

From everyone at Hughes & Associates, we extend our sincere wishes for a safe, enjoyable, and meaningful Fourth of July!

[Hughes & Associates @haallcofficial]

What do 30 recent Clinical Pharmacology job openings reveal about today's talent market?

Our latest analysis highlights trends in hiring demand, scientific capabilities, compensation, work models, leadership, and AI.

Read the full report on our website: https://t.co/aaUK7Iwufl

[Hughes & Associates @haallcofficial]

Clinical Pharmacology hiring continues to evolve.

Our latest 2026 market report explores leadership hiring, compensation, hybrid work, and the skills organizations are prioritizing.

Read full report: https://t.co/a7IIvGkvaB

[Hughes & Associates @haallcofficial]

The best hiring decisions often start before hiring becomes urgent.

Understanding the talent market early can help reduce risk and improve outcomes in specialized biotech and pharma roles.

[Hughes & Associates @haallcofficial]

Today's top translational science talent isn't just technically sharp. They're collaborative, communicative, and influencing decisions at the portfolio level.

We broke this down in our latest market intelligence clip.

For more insights, explore our blog https://t.co/aaUK7Iwufl

[Hughes & Associates @haallcofficial]

Hiring expectations across Clinical Pharmacology, Pharmacometrics, QSP, and DMPK are becoming more specialized as translational sciences teams continue to evolve.

Read our latest Blog: https://t.co/L09cxExmhp

[Hughes & Associates @haallcofficial]

Another episode of why biotech and pharma recruitment has become more strategic in 2026. Shifting hiring priorities to expanding expectations, today’s talent landscape requires a new approach to securing top talents.

Visit our website for more insights. https://t.co/aaUK7Iwufl

[Hughes & Associates @haallcofficial]

Many HR and TA teams are seeing a shift in Clinical Pharmacology and Pharmacometrics searches. Role scope, timing, and flexibility are shaping outcomes.

What’s driving this shift and how is it impacting hiring outcomes?

Full insights: https://t.co/u5fYx80w1X